Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Moreira

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Journal of Endourology|July 9, 2013
Tandem ureteral stents for the decompression of malignant and benign obstructive uropathySammy E Elsamra, Hector Motato, Daniel M Moreira, et al.
European Urology|March 21, 2016
Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy ComplicationsBoris Gershman, Holly K Van Houten, Jeph Herrin, et al.
World Journal of Urology|February 26, 2016
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomyDaniel M Moreira, Boris Gershman, Christine M Lohse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2012
Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE StudyJean-Alfred Thomas, Leah Gerber, Lionel L Bañez, et al.
European Urology|January 26, 2017
Corrigendum re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications" [Eur Urol 2017;71:55-65]Boris Gershman, Holly K Van Houten, Jeph Herrin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 4, 2015
Smoking Is Associated with Acute and Chronic Prostatic Inflammation: Results from the REDUCE StudyDaniel M Moreira, J Curtis Nickel, Leah Gerber, et al.
The Journal of Urology|April 10, 2016
The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE StudyJuzar Jamnagerwalla, Lauren E Howard, Adriana C Vidal, et al.
Annals of Thoracic Medicine|May 5, 2012
Combined use of EUS-guided FNA and immunocytochemical stains discloses metastatic and unusual diseases in the evaluation of mediastinal lymphadenopathy of unknown etiologyMohamad A Eloubeidi, Ali S Khan, Leticia P Luz, et al.
Cancer|December 11, 2013
Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE studyDaniel M Moreira, J Curtis Nickel, Leah Gerber, et al.
Urologic Oncology|September 1, 2015
Clinicopathologic characteristics and survival for adult renal sarcoma: A population-based studyDaniel M Moreira, Boris Gershman, Robert Houston Thompson, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Journal of Endourology|July 9, 2013
Tandem ureteral stents for the decompression of malignant and benign obstructive uropathySammy E Elsamra, Hector Motato, Daniel M Moreira, et al.
European Urology|March 21, 2016
Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy ComplicationsBoris Gershman, Holly K Van Houten, Jeph Herrin, et al.
World Journal of Urology|February 26, 2016
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomyDaniel M Moreira, Boris Gershman, Christine M Lohse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2012
Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE StudyJean-Alfred Thomas, Leah Gerber, Lionel L Bañez, et al.
European Urology|January 26, 2017
Corrigendum re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications" [Eur Urol 2017;71:55-65]Boris Gershman, Holly K Van Houten, Jeph Herrin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 4, 2015
Smoking Is Associated with Acute and Chronic Prostatic Inflammation: Results from the REDUCE StudyDaniel M Moreira, J Curtis Nickel, Leah Gerber, et al.
The Journal of Urology|April 10, 2016
The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE StudyJuzar Jamnagerwalla, Lauren E Howard, Adriana C Vidal, et al.
Annals of Thoracic Medicine|May 5, 2012
Combined use of EUS-guided FNA and immunocytochemical stains discloses metastatic and unusual diseases in the evaluation of mediastinal lymphadenopathy of unknown etiologyMohamad A Eloubeidi, Ali S Khan, Leticia P Luz, et al.
Cancer|December 11, 2013
Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE studyDaniel M Moreira, J Curtis Nickel, Leah Gerber, et al.
Urologic Oncology|September 1, 2015
Clinicopathologic characteristics and survival for adult renal sarcoma: A population-based studyDaniel M Moreira, Boris Gershman, Robert Houston Thompson, et al.
Pageof 15